NEW YORK — Shares of Clovis Oncology climbed Monday after the company reported promising study results for its cancer drug rucaparib.
By The Associated Press, Denver Post: Business
Mon, 09/29/2014 - 12:25pm
NEW YORK — Shares of Clovis Oncology climbed Monday after the company reported promising study results for its cancer drug rucaparib.